This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
North Carolina Medical Journal
  • Menu
  • Articles
    • Correspondence
    • Errata
    • From the NCIOM
    • Letters to the Editor
    • Original Research
    • Policy Forum: Columns
    • Policy Forum: Introduction
    • Policy Forum: Invited Commentaries & Sidebars
    • Policy Forum: Issue Brief
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Subscribe
  • COVID-19 Research
  • For Advertisers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:51057/feed
P-ISSN 0029-2559
E-ISSN 2379-4313
Policy Forum: Invited Commentaries & Sidebars
Vol. 64, Issue 6, 2003November 01, 2003 EDT

The Price of Seduction: Direct-to-Consumer Advertising of Prescription Drugs in the US

Jonathan H. Marks,
CommentaryJonathan H. Marksdirect-to-consumeradvertisingprescription drugsUnited statesprescription drug advertising
https://doi.org/10.18043/ncm.64.6.292
North Carolina Medical Journal
Marks, Jonathan H. 2003. “The Price of Seduction: Direct-to-Consumer Advertising of Prescription Drugs in the US.” North Carolina Medical Journal 64 (6): 292–95. https:/​/​doi.org/​10.18043/​ncm.64.6.292.

View more stats

Powered by Scholastica, the modern academic journal management system